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Abstract
The visual system is composed of various types of cells that all work in conjunction
with one another to send and respond to stimuli from outside of the body. The retina in
particular contains a concentration of cells that mediate vision, including a cell type
known as the melanopsin ganglion cell that express the protein melanopsin. Melanopsin
ganglion cells are intrinsically photosensitive, and are responsible for some aspects of
non-image forming vision, such as maintaining circadian rhythms. Patients with
glaucoma commonly have side effect symptoms associated with malfunctioning circadian
rhythms, indicating a link between glaucoma and melanopsin ganglion cells. In this
study, I traced melanopsin ganglion cells from mouse retinas with and without glaucoma
at various pathological timepoints and took morphological measurements. These
measurements were compared to see if glaucoma had an effect on melanopsin ganglion
cells. The data collected showed that, of the morphological characteristics analyzed in
this study, glaucoma has an effect only on dendritic field size. It appears that in retinas
with glaucoma, melanopsin ganglion cells tend to have a larger dendritic field size than
control cells; further research will help investigate why only this aspect is affected, and in
the manner that it is.

Introduction
Glaucoma is an eye disease that results in an abnormal increase in intraocular
pressure that can result in damage to the optic nerve and in turn blindness; it is the second
leading cause of blindness worldwide. Glaucoma is a chronic and progressive disease,
and is marked by loss of peripheral vision and degeneration of optic nerve fibers and
retinal ganglion cells, or RGCs (Obara et al 2016). An issue experienced by many
patients with glaucoma is an alteration of their circadian rhythms. These circadian rhythm
issues experienced by patients can cause difficulty sleeping, staying awake, waking up,
and concentration as well as fatigue, stress, and even depression. Circadian rhythm
disruption is seen in other neurodegenerative diseases such as Alzheimer’s and
Parkinson’s diseases and is accepted as a “natural consequence” of the diseases, but
studies have shown that they may make the degeneration worse (Lax et al 2019).
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Within the retina, there is a particular cell known as the melanopsin ganglion cell.
These cells express the protein melanopsin, hence their name, coded by the Opn4 gene,
and are considered a third type of photoreceptor (Sondereker et al 2020). Melanopsin
ganglion cells are intrinsically photosensitive, meaning they respond to light without
outside photoreceptor (rod or cone) input, and therefore mediate certain aspects of nonimage forming vision. The most relevant of these aspects within the realm of vision is
their important role in maintaining our circadian rhythms. Because glaucoma and
melanopsin ganglion cells both have a connection to the regulation (and dysregulation) of
circadian rhythms, this project investigates whether or not glaucoma has an effect on the
morphology of these cells that may cause this defect. Because glaucoma causes
dysregulation of circadian rhythms, it is hypothesized that the melanopsin ganglion cells
will be smaller in size from pressure damage and therefore not able to perform their jobs
adequately, resulting in these common issues with light sensing and circadian rhythms in
patients. Previous studies have shown that ablation of M1 ipRGCs result in the loss of
these non-image forming behaviors (Sondereker et al 2020).

Methods
DBA/2J mouse retinas from control and glaucomatous retinas at various
pathological timepoints were dissected, fixed, and stained using immunohistochemistry.
The DBA/2J mouse line is a well-accepted model as they are predisposed to spontaneous
pigmentary glaucoma,
characterized by intraocular
pressure elevation and progressive
death of retinal ganglion cells with
age, closely resembling human
glaucoma (Zhang et al 2013).
This immunohistochemistry uses
antibodies that tag the

The Jackson Laboratory

Sondereker et al 2018

Sondereker et al 2018

Figure 1: Mouse retinas were transected and stained with
antibodies that tag melanopsin protein. The retinas were then
imaged and cells that expressed melanopsin would fluoresce.
Scale bars = 1 mm. Mouse photo credit: The Jackson Laboratory
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melanopsin protein. During imaging, the cells that express this protein will fluoresce
green, allowing the mRGCs to be differentiated from other retinal cells. The retinas were
then imaged using confocal imaging to create a z-stack of images that can be loaded into
a specialized computer program known as ImageJ as a .tif file; each retina was divided
into quadrants, so each .tif file is a quadrant of a particular retina with the melanopsin
ganglion cells marked to be traced. ImageJ has a subprogram known as Simple Neurite
Tracer that allows the user to automatically follow and digitally trace the dendrites of a
single cell throughout the image stack, following and connecting the pixels to make a 2D
image of how the dendrites stratify throughout the retinal quadrant.
Once all of the dendrites on an individual
melanopsin ganglion cell neuron are traced,
ImageJ has various measurement features that
allow for measurements to be taken of
morphological characteristics such as soma size,
total dendritic length, and total dendritic field size.
This process of measurement was repeated with
each traced cell in every quadrant until each
melanopsin ganglion cell in a full retina is traced,
Figure 2. ipRGC of a 4-month
glaucomatous mouse retina traced
using ImageJ. Scale bar = 15 microns.

and then the process was further repeated on
another retina. This was repeated until enough data

was obtained to compare between control and glaucomatous groups, as well as at
different pathological timepoints such as early, mid, and late-stage glaucoma. As this is a
major undertaking of data collection, data collected by multiple undergraduate students
over the span of 4 years was analyzed for this project. This data was then statistically
analyzed between groups using an ANOVA test with GraphPad InStat.
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Results
Upon ANOVA analysis testing of the traces of 103 glaucomatous mouse retinal
cells and 88 control mouse retinal cells, it was found that the differences in average soma
size and total dendritic length were not significant. However, the differences in average
dendritic field size between the two groups was significant. This significance was
determined using the q value given as a result of the Tukey-Kramer Multiple
comparisons test following the ANOVA. This indicates that glaucoma only affects
certain morphological aspects of melanopsin ganglion cells; for this study, this is only in
dendritic field size, which seems to be increased in glaucomatous retinas.
Glaucomatous
Sample Size (n=):
Soma Size:
Mean (microns)
Standard Error (microns)
Tukey-Kramer Multiple
Comparisons test, q value
Total Dendritic Length:

Control

103
Glaucomatous

88
Control

15.36

14.62

0.2684

0.2126

0.000459
Glaucomatous

not significant
Control

Mean (microns)

1358

1119

Standard Error (microns)

58.88

49.13

Tukey-Kramer Multiple
Comparisons test, q value

0.1485

Dendritic Field Size:
Mean

(microns2)

Glaucomatous

not significant
Control

52746

44710

Standard Error (microns2)

3501

2732

Tukey-Kramer Multiple
Comparisons test, q value

4.982

significant

Table 1. Glaucomatous versus control melanopsin ganglion cell traces. This table
analyzes the means, standard errors, and q values from the Tukey-Kramer Multiple
Comparisons test for each variable (soma size, total dendritic length, and dendritic field
size.) The q value must be over 4.03 to be considered significant based on the data entry.
The only aspect that is significantly different between the two data sets is dendritic field
size.
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Average Soma Size in
Glaucomatous versus Control
Mice Neurons
16.00

Soma size (microns)

Figure 3. Average soma size as
measured between glaucomatous and
control mice melanopsin ganglion cell
traces. There is no significant difference
between the two data sets.
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Average Total Dendritic Length in
Glaucomatous versus Control
Mice Neurons
1600

Figure 4. Average total dendritic length
as measured between glaucomatous and
control mice melanopsin ganglion cell
traces. There is no significant difference
between the two data sets.
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Figure 5. Average total dendritic field size
as measured between glaucomatous and
control mice melanopsin ganglion cell
traces. There is a significant difference
between the two data sets, indicating that
glaucoma has an effect on this aspect of
morphology.
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Discussion
After statistically analyzing a number of traces from glaucomatous and control mouse
retinal ganglion cells, findings show that the only morphological aspect of these cells affected by
glaucoma is dendritic field size. The original expectations of results were that perhaps the cells
would become morphologically smaller from pressure damage, but it appears that this is not the
case; soma size and dendritic length is the same between groups, but dendritic field size
increases. This increase in field size but maintenance of dendritic length implies that on average
there may be fewer dendrites found in glaucomatous cells, but they reach further than that of the
controls for these numbers to alter in such a way. It is possible that a decrease in total dendrites
(and potentially total number of cells in a glaucomatous retina) may cause an overcompensation
of field size to be able to still fully span the retina. This would be an unsurprising find, as it is
important to note that melanopsin ganglion
cells have been found in various studies to
be incredibly resistant to injury when
compared to other retinal ganglion cells, so
this could be another form of damage
resistance (Lax et al 2019). A similar
finding has come from studies with other
rodent models, such as in a rat ocular
hypertension model, where very few
melanopsin ganglion cells degenerated
compared to other RGCs (Li et al 2006). In
particular, this injury resistance in specific
regards to elevated intraocular pressure has
been shown in the M1 subtype of

Figure 6. Histological arrangement of retinal structure.
M1 and M1d somas can be found in the GCL and INL.
Image from Triviño et al 2012.

melanopsin ganglion cell which was the
focus of this study; results may differ in the M4 subtype, as they have been shown to suffer
significant loss of cells with elevated IOP (Gao et al 2022). Therefore, the implication of this and
other studies on the subject is likely not uniform among the different subtypes of melanopsin
ganglion cells. It is, however, important to note some shortcomings of this study and others of its
kind in terms of takeaway for human usage in early detection and treatment: human retinas are
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fairly different in distribution of retinal ganglion cells compared to rodent models. Human retinas
have melanopsin ganglion cells evenly distributed
throughout the ganglion cell layer (GCL) and inner
nuclear layer (INL), but these cells vary in shape and
diameter from each other. The highest density of
melanopsin ganglion cells were located around the
fovea, an anatomical aspect that mice do not possess.
M1 and displaced M1s are mainly concentrated in the
temporal retina in humans (Hannibal et al 2017). In
mice, they are asymmetrically distributed to the dorsal
retina (Sondereker et al 2020) and in rats they are at a
slightly higher density in the upper-temporal part of
Figure 7. Distribution of melanopsin
ganglion cell subtypes in the mouse
retina. Image from Sondereker et al 2020.

the retina (Lax et al 2019). It is important to take
these anatomical differences into account when
considering clinical implications.

In regards to the findings of this particular study, we can assume that the lack of
morphological change of certain aspects of melanopsin ganglion cells can be attributed to the
aforementioned resistance to injury. Further studies could be performed to investigate reasons for
the increase in dendritic field size of glaucomatous cells, focusing more in depth on pathological
timepoints or specific retinal quadrant. This study looked at the effect on the cells as a whole, so
cells analyzed included the pathological timepoints of 3 months, 5 months, and 7 months, but did
not take into account the potential difference of dendritic field size at each of these timepoints
individually. It is likely that in the older retinas that have further progressed glaucoma, the more
damage to the cells. This can be hypothesized off of the basis that in human eyes with glaucoma,
studies have shown that a small decline in mRGCs occurs after the age of 50, marked by a stark
loss of 44% after 70 years old (Lax et al 2019). In the same way, cells from temporal, dorsal,
nasal, and ventral quadrants were analyzed all together; because of the difference in distribution
patterns between models, it would be worthwhile to analyze cells from each quadrant separately
to see if the distribution affects morphology as well in glaucomatous cells. It is evident that these
cells have a special connection to this disease and others, and further studies will help uncover
more attributes of their relationship.
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